Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-88723173 |
| Mobile: | 18596073690 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (2-methyl-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)methanol | C9H10F3NO2 | 1373863-05-8 | Details |
| Amisulpride EP Impurity D | C16H25N3O4S | 71676-00-1 | Details |
| Olopatadine Impurity 24 | C22H26Br2NP | 4174-83-8 | Details |
| Methyl Cholate | C25H42O5 | 1448-36-8 | Details |
| METHYL DESOXYCHOLATE | C25H42O4 | 3245-38-3 | Details |
| Glyceryl triundecanoate | C36H68O6 | 13552-80-2 | Details |
| Olopatadine Impurity 55 | C21H24Br2NP | 4174-84-9 | Details |
| Methyl Chenodeoxycholate | C25H42O4 | 3057-04-3 | Details |
| Olopatadine Impurity 39 | C22H24BrOP | 111088-69-8 | Details |
| Fudosteine Impurity Q | Details |
| tert-butyl ((1S,2R,5R)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate | C14H27N3O3 | 2089454-69-1 | Details |
| Celecoxib 2-Methyl Analog | C17H14F3N3O2S | 170569-99-0 | Details |
| Vonoprazan Impurity 24 | C16H14FN3O2S | 1807642-41-6 | Details |
| Propranolol EP Impurity C | C23H20O3 | 17216-10-3 | Details |
| Vitamin B6 Impurity 1 | C10H15NO3 | 765235-25-4 | Details |
| Propranolol EP Impurity A | C13H14O3 | 36112-95-5 | Details |
| Dibenzosuberone | C15H12O | 1210-35-1 | Details |
| N-DesMethyl Olopatadine | C20H21NO3 | 113835-92-0 | Details |
| Indometacin EP Impurity I | C21H20ClNO4 | 16401-99-3 | Details |
| Cyproheptadine EP Impurity C | C21H23NO | 3967-32-6 | Details |
| Indometacin EP Impurity E | C19H16ClNO4 | 807614-94-4 | Details |
| Rosuvastatin EP Impurity D | C22H26FN3O5S | 503610-43-3 | Details |
| 5-Methyl-3-phenylisoxazole-4-carbonyl chloride | C11H8ClNO2 | 16883-16-2 | Details |
| 1-(naphthalen-2-yloxy)-3-[(propan-2-yl)amino]propan-2-ol | C16H21NO2 | 2007-72-9 | Details |
| Dabigatran Impurity E | C32H37N7O5 | 212321-78-3 | Details |
| Dabigatran Impurity N | C32H36N6O6 | 1408238-37-8 | Details |
| hexyl aMino(4-aMinophenyl)MethylenecarbaMate hydrochloride | C14H22ClN3O2 | 1307233-93-7 | Details |
| N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | C27H30ClN7O3 | 211914-50-0 | Details |
| Dabigatran Impurity A | C34H40N6O6 | 1408238-40-3 | Details |
| Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity) | C26H33N5O4 | 1408238-36-7 | Details |
| N-[[2-[[(4-Cyanophenyl)aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine | C25H22N6O3 | 212322-77-5 | Details |
| 4-AMINO-5,6-DICHLOROBENZENE-1,3-DISULFONAMIDE | C6H7Cl2N3O4S2 | 5250-72-6 | Details |
| 2-Amino-4-trifluoromethylbenzonitrile | C8H5F3N2 | 1483-54-1 | Details |
| Dabigatran Impurity O | C19H20N4O3 | 1702936-92-2 | Details |
| 5-Methyl-3-phenylisoxazole-4-carboxylic acid | C11H9NO3 | 1136-45-4 | Details |
| 6-Aminopenicillanic acid | C8H12N2O3S | 551-16-6 | Details |
| 1-(3-CHLOROMETHYL-4-HYDROXY-PHENYL)-ETHANONE | C9H9ClO2 | 24085-05-0 | Details |
| Dabigatran Impurity 9 | C19H21N5O2 | 1408238-41-4 | Details |
| Dabigatran Impurity J | C33H39N7O5 | 1416446-45-1 | Details |
| Dabigatran Impurity P | C27H28N6O4 | 1422435-41-3 | Details |
| Dabigatran Impurity 24 | C20H22N4O3 | 1456889-80-7 | Details |
| Dabigatran Impurity L | C32H38N8O4 | 1580491-16-2 | Details |
| 4-Aminobenzamidine dihydrochloride | C7H11Cl2N3 | 2498-50-2 | Details |
| Dabigatran Impurity F | C35H43N7O5 | 1610758-21-8 | Details |
| Dabigatran Impurity C | C34H41N7O5 | 1610758-20-7 | Details |
| ethyl 3-(1-methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate | C19H20N4O4 | 1642853-67-5 | Details |
| Dabigatran Impurity G | C35H43N7O5 | 1610758-19-4 | Details |
| TAUROURSODEOXYCHOLIC ACID SODIUM SALT | C26H46NNaO6S | 35807-85-3 | Details |
| Dabigatran Impurity 25 | C25H26N8O2 | 1643377-48-3 | Details |
| 2,6-DIMETHYLTHIOPHENOL | C8H10S | 118-72-9 | Details |
| (3S,4R)-3-ethyl-4-(3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide | C24H25F3N6O3S | 2411540-30-0 | Details |
| (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate | C14H22O4 | 204254-96-6 | Details |
| Ethyl (3R,4R,5S)-5-N,N-diallylamino-4-(1,1-dimethylethyl)amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate | C24H42N2O3 | 651324-06-0 | Details |
| (trans)-4-(((trans)-4-(aminomethyl)cyclohexanecarboxamido)methyl) cyclohexanecarboxylic | C16H28N2O3 | 82755-59-7 | Details |
| Upadacitinib Impurity 23 | C20H21F6N7O2 | 2715120-86-6 | Details |
| Ethyl (1R,5R,6R)-7-(tert-butyl)-5-(pentan-3-yloxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylate | C18H31NO3 | 2417645-75-9 | Details |
| Imatinib Impurity V | C29H31N7O3 | 571186-93-1 | Details |
| Bortezomib ImpurityN | C19H24N4O4 | 886979-78-8 | Details |
| Bortezomib Impurity M | C19H24N4O4 | 886979-81-3 | Details |
| 4-(4-(3-(2-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| Dibenz[b,f]azepine-5-carbonyl chloride | C15H10ClNO | 33948-22-0 | Details |
| 2-(Cyanomethylthio)acetic acid | C4H5NO2S | 55817-29-3 | Details |
| cefmetazole | C15H18N10O5S3 | 784228-11-8 | Details |
| (Z)-ethyl 5-((5-fluoro-2-oxoindolin-3-ylidene)Methyl)-2,4-diMethyl-1H-pyrrole-3-carboxylate | C18H17FN2O3 | 1104253-05-5 | Details |
| Butylphthalide Impurity | C13H17NO | 122654-49-3 | Details |
| Nintedanib Impurity 36 | C17H13NO4 | 2093243-16-2 | Details |
| Nintedanib-013-CO | C17H13NO4 | 2218446-42-3 | Details |
| Nintedanib Impurity 16 | C18H15NO4 | 1438271-13-6 | Details |
| Nintedanib Impurity 18 | C12H11NO5 | 2514952-69-1 | Details |
| Nintedanib Impurity 2 | C9H9ClN2O3 | 2653-15-8 | Details |
| Moxifloxacin EP Imp.B | C22H27N3O5 | 1029364-73-5 | Details |
| Moxifloxacin Related Compound A (HCl salt form) | C20H22ClF2N3O3 | 151282-23-4 | Details |
| Bumetanide EP Impurity B | C13H12N2O5S | 28328-54-3 | Details |
| Cefotaxime Impurity 7(Cefotaxime EP Impurity G) | C22H22N8O9S3 | 2489535-06-8 | Details |
| (R)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine | C12H19NO4S | 608142-27-4 | Details |
| 2,2'-METHYLIMINOBIS-(ACETALDEHYDE DIMETHYL ACETAL) | C9H21NO4 | 70887-96-6 | Details |
| (Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate | C24H21N3O3 | 1987887-92-2 | Details |
| Nintedanib Impurity | C9H8Cl2N2O3 | 78466-25-8 | Details |
| 2,6-DiMethoxy-1,4-benzoquinone | C8H8O4 | 530-55-2 | Details |
| 4-Nitro-2-phenoxyaniline | C12H10N2O3 | 5422-92-4 | Details |
| Intedanib Impurity | C30H31N5O4 | 894783-71-2 | Details |
| diethyl 2-(3-methylbutylidene)propanedioate | C12H20O4 | 51615-30-6 | Details |
| (3-methyl-6-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol | Details |
| 2,2'-(piperazine-1,4-diyl)bis(N-(4-aminophenyl)-N-methylacetamide) | C22H30N6O2 | 2410284-89-6 | Details |
| S-Methyl Cefmetazole | C15H17N7O4S4 | 68576-47-6 | Details |
| Nintedanib Impurity | C26H23N3O4 | 1139458-48-2 | Details |
| (5-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanol | C9H10F3NO2 | 103577-73-7 | Details |
| 4-[(2R)-2-(3,4,5,6-tetrahydro-2H-pyran-2-yloxy)-propionyl]morpholine | C12H21NO4 | 135270-08-5 | Details |
| Sirolimus isomer C | C51H79NO13 | 150821-39-9 | Details |
| Pentoxifylline Impurity 13 | C13H20N4O4 | 84321-40-4 | Details |
| Dabigatran Etexilate iMpurity O | C35H43N7O5 | 1349500-09-9 | Details |
| Nintedanib impurity G | C30H31N5O4 | 894783-61-0 | Details |
| Nintedanib impurity | C56H52N8O8 | 2410284-90-9 | Details |
| Methyl 3,7-Di-O-acetylcholate | C29H46O7 | 3749-87-9 | Details |
| Nintedanib Impurity 30 | C9H10N2O4 | 1860012-61-8 | Details |
| Nintedanib Impurity 30 | C13H18N4O3 | 1038972-16-5 | Details |
| Methyl 1-acetyl-2-oxoindoline-6-carboxylate | C12H11NO4 | 676326-36-6 | Details |
| Intedanib Impurity | C13H20N4O | 2243384-71-4 | Details |
| Nintedanib Impurity | C22H26N6O6 | 2410649-54-4 | Details |
| Cefpodoxime Proxetil EP Impurity A | C15H17N5O6S2 | 80210-62-4 | Details |
| Product Total： Product Page： | ||||
| 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 | ||||